MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.

An AI model using deep transfer learning—the most advanced form of machine learning—has predicted spoken language outcomes with 92% accuracy from one to three years after patients received cochlear ...

Youth with congenital deafness treated with gene therapy showed better progress on certain hearing measures than counterparts treated with cochlear implantation in a cohort study from China. Gene ...

Suggested Citation: "1 Introduction." National Academies of Sciences, Engineering, and Medicine. 2021. Evaluating Hearing Loss for Individuals with Cochlear Implants ...

An experimental gene therapy for a rare form of genetic deafness has successfully restored hearing in children and adults, ...

Genetic deficiency of otoferlin, a protein critical to synaptic transmission by the sensory hair cells of the ear, causes congenital deafness. Medicines to treat the condition are lacking; children ...

The FDA approved lunsotogene parvec-cwha as the first gene therapy for genetic hearing loss caused by biallelic OTOF variants ...

More older adults have turned to cochlear implants after Medicare expanded eligibility for the devices. By Paula Span Kitty Grutzmacher had contended with poor hearing for a decade, but the problem ...

Suggested Citation: "3 Characteristics and Limitations of the Hearing in Noise Test." National Academies of Sciences, Engineering, and Medicine. 2021. Evaluating Hearing Loss for Individuals with ...